miR-106b-5p and miR-17-5p could predict recurrence and progression in breast ductal carcinoma in situ based on the transforming growth factor-beta pathway
2019 ◽
Vol 176
(1)
◽
pp. 119-130
◽
1992 ◽
Vol 28
(2-3)
◽
pp. 641-644
◽
2009 ◽
Vol 69
(23)
◽
pp. 9148-9155
◽
2003 ◽
Vol 36
(3)
◽
pp. 373-381
◽
2001 ◽
Vol 88
(3)
◽
pp. 412-418
◽
2018 ◽
Vol 228
◽
pp. 303-307
◽